Börge Seeger is a partner at NEUWERK Rechtsanwälte. His practice covers all aspects of IP and IT law, including IP licensing and partnering, technology transfers, joint ventures and alliances, software and IT outsourcings, data protection and privacy, as well as complex commercial law matters.
In addition, Mr Seeger has extensive experience in assisting clients from the life sciences and healthcare sector. He regularly advises biotechnology companies, pharmaceutical companies and medical device manufacturers on product divestitures, licensing arrangements, R&D collaborations, clinical trial agreements and distribution matters, as well as on numerous other issues relating to the development, manufacture and marketing of their products. At NEUWERK, he heads the life sciences focus group.
Mr Seeger recently advised Polpharma Biologics, a leading European biopharmaceutical company, on a global cooperation and licensing agreement for the joint development and marketing of biosimilar Natalizumab with Novartis generics subsidiary Sandoz. He also recently advised ITG, a German-based specialised radiopharmaceutical company, on a long-term global supply and licence agreement with Novartis subsidiary and French cancer specialist AAA.
Recommended as “incredibly responsive” and “fun to work with”, Mr Seeger is praised by clients as “our go-to guy” for both IP and IT matters.
Mr Seeger is a German lawyer and certified licensing professional. He is a co-author and editor of Newsdienst Compliance – one of Germany’s leading law journals for corporate and compliance managers, published by CH Beck – in which he publishes on current IP, licensing, IT and data protection issues. He has also co-authored the second edition of the German Handbook of Pharmaceutical Contracts.
Mr Seeger is a lecturer at the Center for Transnational IP, Media and Technology Law and Policy at Bucerius Law School (Hamburg, Germany), and a fellow at the Center for Internet and Society at Stanford Law School, United States. He is active in a number of trade and professional associations, and is a regular speaker on IP and IT issues at workshops and professional conferences.